[{"Assets_0_Q3_USD":78470167.0,"CommonStockSharesOutstanding_0_Q3_shares":156425904.0,"NetIncomeLoss_1_Q3_USD":-5452521.0,"NetIncomeLoss_3_Q3_USD":-13028382.0,"StockholdersEquity_0_Q3_USD":35996619.0,"Ticker":"ATRS","CIK":"1016169","name":"ANTARES PHARMA, INC.","OfficialName":"Antares Pharma Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"948492298.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NASDAQ","SP500":"nan","filed":"20171107"}]